(Press-News.org) Pasadena, CA— The structures and star populations of massive galaxies appear to change as they age, but much about how these galaxies formed and evolved remains mysterious. Many of the oldest and most massive galaxies reside in clusters, enormous structures where numerous galaxies are found concentrated together. Galaxy clusters in the early universe are thought to be key to understanding the lifecycles of old galaxies, but to date astronomers have located only a handful of these rare, distant structures.
New research from a team led by Carnegie's Andrew Newman has confirmed the presence of an unusually distant galaxy cluster, JKCS 041. It is published by the Astrophysical Journal.
"Our observations make this galaxy cluster one of the best-studied structures from the early universe," Newman said.
Although the team began studying JKCS 041 in 2006, it has taken years of observing with many of the world's most powerful telescopes to finally confirm its distance. The team used the Hubble Space Telescope to capture sharp images of the distant cluster and split the starlight from the galaxies into its constituent colors, a technique known as spectroscopy. They found 19 galaxies at precisely the same great distance of 9.9 billion light years, the tell-tale sign of an early galaxy cluster.
A previous study using the Chandra X-ray Observatory discovered X-ray emissions in the location of JKCS 041.
"These X-rays likely originate from hot gas in JKCS 041, which has been heated to a temperature of about 80 million degrees by the gravity of the massive cluster," said team member Stefano Andreon of the Osservatorio Astronomico di Brera, who led a companion paper published by Astronomy & Astrophysics, which is available here.
Today the largest and oldest galaxies are found in clusters, but there is a mystery about when and why these giant galaxies stopped forming new stars and became dormant, or quiescent. Peering back to a time when the galaxies in JKCS 041 were only 1 billion years old---or 10 percent of their present age---the team found that most had already entered their quiescent phase.
"Because JKCS 041 is the most-distant known cluster of its size, it gives us a unique opportunity to study these old galaxies in detail and better understand their origins," Newman said.
Once massive galaxies enter their quiescent phase, they continue expanding in overall size. This is thought to occur as galaxies collide with one another and evolve into a new, larger galaxy. Early clusters are suspected to be prime locations for these collisions, but to the team's surprise they found that the galaxies in JKCS 041 were growing at nearly the same rate as non-cluster galaxies.
INFORMATION:
The international team included Newman, Andreon, Ginevra Trinchieri of the Osservatorio Astronomico di Brera, Richard Ellis of Caltech, Tommaso Treu of the University of California at Santa Barbara, and Anand Raichoor of the Observatorie di Paris.
This work was based on observations made with the NASA/ESA Hubble Space Telescope, obtained at the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract NAS 5-26555. These observations are associated with program number GO-12927, which was supported under NASA contract NAS 5-26555. The work was also supported by the agreement ASI-INAF I/009/10/0 and the Osservatorio Astronomico di Brera.
The Carnegie Institution for Science is a private, nonprofit organization headquartered in Washington, D.C., with six research departments throughout the U.S. Since its founding in 1902, the Carnegie Institution has been a pioneering force in basic scientific research. Carnegie scientists are leaders in plant biology, developmental biology, astronomy, materials science, global ecology, and Earth and planetary science.
Very distant galaxy cluster confirmed
2014-05-21
ELSE PRESS RELEASES FROM THIS DATE:
Skinny lens makes cheap surveillance camera for home use
2014-05-21
WASHINGTON, May 21, 2014—Dark alleys might not feel so dangerous someday thanks to a new ultra-thin type of lens, which could pave the way to making smaller and cheaper heat-sensing imagers. A team of French researchers has found a way to make a thermal infrared (IR) camera with a lens made of silicon, a much less expensive material than is commonly used today.
The new silicon lens is as thick as a fingernail with a diameter less than that of a No. 2 pencil. Although its resolution is not superb, the lens is good enough to reveal the presence of a person and some general ...
Novel RNAi therapy silences mutated Huntington's disease gene and reduces symptoms
2014-05-21
New Rochelle, NY, May 21, 2014—A targeted gene silencing strategy blocks production of the dysfunctional huntingtin (Htt) protein, the cause of Huntington's disease, a fatal, inherited neurodegenerative disorder. The effectiveness of this RNA interference (RNAi) approach in reducing levels of mutant Htt protein and disease symptoms in a mouse model of the disease is described in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Human Gene Therapy website.
Lisa Stanek and coauthors from Genzyme (Framingham, ...
Questions raised about physio for hip osteoarthritis
2014-05-21
Hip osteoarthritis is a prevalent and costly chronic musculoskeletal condition. Clinical guidelines recommend physiotherapy as treatment, although its effectiveness has never been proven.
Now, a study led by the University's Professor Kim Bennell has found that among adults with painful hip osteoarthritis, physical therapy does not produce greater improvements in pain or function compared with a placebo treatment.
In an article published in the prestigious Journal of the American Medical Association, Professor Bennell and her colleagues randomly assigned patients with ...
In your genes: Family history reveals predisposition to multiple diseases
2014-05-21
The family history screening questionnaire can be used to provide insight into people's susceptibility to breast, ovarian, bowel and prostate cancer, melanoma, ischaemic heart disease and type 2 diabetes.
These findings will lead to greater insight into the process of preventative treatment for cancer in primary care and provide a cost-effective intervention for tailored disease prevention in Australian primary care..
Lead researcher Professor of Primary Care Cancer Research at the University of Melbourne Jon Emery said this research is the first of its kind to validate ...
Finnish researchers discovered a new anticancer compound
2014-05-21
A team of research scientists from VTT Technical Research Centre of Finland, the University of Turku and the University of Eastern Finland has discovered a previously unknown Cent-1 molecule that kills cancer cells. Their research also shows that new cancer drug candidates can be identified faster and at lower cost by using computer-assisted and cell-based screening of compounds.
The objective of the research project led by Marko Kallio, Principal Scientist at VTT, was to accelerate the drug development process by identifying new compounds that would possess similar binding ...
Personalizing revascularization strategy for STEMI patients is vital, EuroPCR panel finds
2014-05-21
21 May 2014, Paris, France: A Great Debate at EuroPCR 2014 saw experts discussing the role of the two most valuable strategies to save the lives of ST-segment Elevation Myocardial Infarction (STEMI) patients: primary percutaneous coronary intervention (PCI) and thrombolysis.
Both these are effective treatments that actively save lives, and when there is no option for primary percutaneous coronary intervention, thrombolysis is the way to proceed, participants heard. The topic of the Great Debate, 'Primary PCI for STEMI: an emergency!' was selected ahead of the session ...
EuroPCR 2014 showcases technological advances in complex cardiovascular interventions
2014-05-21
St Jude Medical's Nanostim device and Medtronic's Micra, both single-chamber leadless pacing systems, and the most advanced commercially available valve, the Edwards Sapien 3 Transcatheter Heart Valve (Edwards Life Sciences) featured in the discussions.
With regard to leadless pacing, participants heard that there was a need for a novel system that provides reliable pacing and sensing, and addresses the challenges of current pacing systems by minimising the risks of infection, pneumothorax, dislodgement and long-term infection.
Prof Panos Vardas, University Hospital ...
Laser light needs more bass
2014-05-21
They shed light on atomic and molecular processes: ultrashort laser pulses are required to study extremely fast quantum phenomena. For years, scientists have been trying to tune the shape of light waves so as to, for instance, steer an electron on exactly the right path. At the TU Vienna, an extraordinarily powerful new method to influence the shape of the laser light wave has been developed in cooperation with the Imperial College in London and the Max-Born-Institute in Berlin. Much like the characteristic sound of a musical instrument, which results from the combination ...
Research breakthrough paves the way for understanding serious diseases
2014-05-21
A few years ago researchers described a Turkish family whose family members moved around on all fours. It turned out that they lacked the sense of equilibrium. This was caused by the rare neurological disease CAMRQ, which is the result of a mutation in the lipid pump in the cells. On the other hand, it was not known why the genetic error had such serious consequences.
The discovery provided inspiration for a Danish study of the mechanism for the vital lipid pump function, the so-called flippase, which transports lipids in the membrane that surrounds every single cell ...
Dolutegravir in HIV-1 infection: Added benefit in adult patients
2014-05-21
Dolutegravir has been approved since January 2014 in combination with other antiretroviral drugs for the treatment of human immunodeficiency virus (HIV) infected adults and adolescents above 12 years of age. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) now examined whether the new drug offers an added benefit over the appropriate comparator therapy.
The dossier compiled by the drug manufacturer provided proof of a considerable added ...